A Study to Assess Kidney Function Markers in Transgender Individuals Receiving Gender-affirming Hormone Therapy
Rochester, MN
The purpose of this study is to determine how cystatin C, creatinine, and microalbuminuira change with gender affirming hormone therapy initiation. Blood draws and urine testing will be done at time 0, 3 months, and 6 months of hormone therapy. The results will determine how to best interpret lab values in transgender individuals receiving gender affirming hormone therapy.